Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...
In this article, we will discuss the 9 Best Biotech Penny Stocks to Buy in 2026. On April 24, Drew Pettit, Citi US equity ...
Biotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets ...
Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 10 best biotech stocks with highest upside potential. On April 6, Denali ...
Apple — Shares were up 2%. For the fiscal second quarter , Apple's earnings came in at $2.01 per share, while revenue landed ...
Legend Biotech ( LEGN +18.42%) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...
An analyst initiated coverage of the biotech.
Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory ...
Michael Yee, UBS global head of biotech research, joins 'Squawk Box' to discuss the quarterly earnings results of Merck and Eli Lilly, opportunities in pharma stocks, and more.
Stockhead on MSN
Biocurious: Why biotech’s big end of town has lost its mojo
Cochlear, CSL and Pro Medicus have been hard hit by disparate concerns, many of which investors suspect are structural rather ...
Compass Therapeutics says a treatment evaluating its cancer treatment didn’t meet the secondary endpoint for an unexpected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results